Infosys launches cloud-based version of its CTSM solution

05 Jun 2014

Infosys, a global leader in technology, consulting and outsourcing, has launched a cloud-based version of its Clinical Trial Supply Management (CTSM) solution. The new solution helps life sciences companies enhance efficiency of clinical trial processes by driving greater collaboration between pharmaceutical companies and contract research organizations (CROs).

This solution helps to improve the productivity of the overall drug development process. It also helps ensure the timely and accurate supply of drugs to patients at reduced costs. As a result, enterprises can price products competitively while adhering to the stringent standards required to bring products safely to consumers.

The new cloud-based version of the CTSM solution is an enhancement to the existing on-premise version of the CTSM solution – CTSM Add-On Suite 2.2 by Lodestone – that offers a complete set of tools to manage all aspects of complex clinical trials. This covers demand and supply planning as well as distribution across clinical sites. The on-premise version of the solution has been successfully managing clinical trial processes at a number of large global pharmaceutical companies across the US and Europe.

Related Infosys Ltd. Links:

Infosys Share Price

1316.80 -10.15 (-0.76%) May 14, 18:01
1 Year Price Chart
Peers
Company Name CMP
TCS 3050.75
Infosys 1316.80
HCL Tech. 910.30
Wipro 498.35
Tech Mahindra 951.95
View more..
Sensex vs Infosys
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback